BEGIN:VCALENDAR VERSION:2.0 PRODID:-//141.193.213.11//NONSGML kigkonsult.se iCalcreator 2.20// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:https://catalyst-hm.com X-WR-TIMEZONE:America/New_York BEGIN:VTIMEZONE TZID:America/New_York X-LIC-LOCATION:America/New_York BEGIN:STANDARD DTSTART:20231105T020000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST END:STANDARD BEGIN:DAYLIGHT DTSTART:20240310T020000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:ai1ec-205591@catalyst-hm.com DTSTAMP:20240329T101507Z CATEGORIES;LANGUAGE=en-US:Grand Rounds\,New York CONTACT: DESCRIPTION:Tuesday\, September 7\, 2021\n12:00-1:00pm\nLocation\nBrooklyn\ , NY\nSpeaker\nDavid Rizzieri\, MD DTSTART;TZID=America/New_York:20210907T120000 DTEND;TZID=America/New_York:20210907T130000 LOCATION:Brooklyn\, NY SEQUENCE:0 SUMMARY:AML Grand Rounds URL:https://catalyst-hm.com/event/aml-grand-rounds-14/ X-COST-TYPE:free X-ALT-DESC;FMTTYPE=text/html:\\n\\n
\\nT
uesday\, September 7\, 2021
\n12:00-1:00pm
Location
strong>
\nBrooklyn\, NY
Speaker
\nDavid
Rizzieri\, MD
T
uesday\, September 7\, 2021
\n2:00-3:00pm
Location
\nHouston\, TX
Speaker
\nDavid R
izzieri\, MD
T
hursday\, September 9\, 2021
\n12:00-1:00pm
Location<
/strong>
\nChicago\, IL
Speaker
\nAlice
S. Mims\, MD\, MSCR
T
hursday\, September 9\, 2021
\n4:30-5:30pm
Location
strong>
\nBaltimore\, MD
Speaker
\nAlic
e S. Mims\, MD\, MSCR
F
riday\, September 10\, 2021
\n12:00-1:00pm
Location
strong>
\nCanton\, OH
Speaker
\nDavid R
izzieri\, MD
T
uesday\, September 14\, 2021
\n12:00-1:00pm
Location<
/strong>
\nHudson\, NY
Speaker
\nDavid
Rizzieri\, MD
T
hursday\, September 23\, 2021
\n10:00-11:00am
Locatio
n
\nStaten Island\, NY
Speaker
\nJeffrey E. Lancet\, MD
T
hursday\, September 23\, 2021
\n12:00-1:00pm
Location
\nTemple\, TX
Speaker
\nAlice
S. Mims\, MD\, MSCR
F
riday\, September 24\, 2021
\n12:15-1:15pm
Location
strong>
\nDecatur\, GA
Speaker
\nJoshua
Zeidner\, MD
M
onday\, September 27\, 2021
\n12:00-1:00pm
Location
strong>
\nBrooklyn\, NY
Speaker
\nDavid
Rizzieri\, MD
M
onday\, September 27\, 2021
\n7:30-8:30am
Location
\nWhite Plains\, NY
Speaker
\nHe
tty Carraway\, MD\, MBA
S
aturday\, October 2\, 2021
\n12:00-1:00pm
Location
\nLubbock\, TX
Speaker
\nTapan M
. Kadia\, MD
Date: Wednesday\, October 6\, 2021
\n
Time: 7:00 PM – 9:00 PM EST
To pre-register for the live event\, please visit www.MLG-HM.com or call 1-207-847-0613
\n\nT
hursday\, October 7\, 2021
\n12:00-1:00pm
Location
\nChicago\, IL
Speaker
\nHetty C
arraway\, MD\, MBA
T
hursday\, October 14\, 2021
\n12:00-1:00pm
Location
strong>
\nN/A
Speaker
\nAlice S. Mims\,
MD\, MSCR
W
ednesday\, October 20\, 2021
\n12:15-1:15pm
Location
\nOxnard\, CA
Speaker
\nDavid
Rizzieri\, MD
T
hursday\, October 21\, 2021
\n7:30-8:30am
Location
\nPhiladelphia\, PA
Speaker
\nTa
pan M. Kadia\, MD
F
riday\, October 22\, 2021
\n8:00-9:00am
Location
\nBrooklyn\, NY
Speaker
\nAnjali A
dvani\, MD
W
ednesday\, October 27\, 2021
\n12:00-1:00pm
Location<
/strong>
\nHoboken\, NJ
Speaker
\nJoshu
a Zeidner\, MD
T
hursday\, October 28\, 2021
\n12:00-1:00pm
Location
strong>
\nN/A
Speaker
\nAlice S. Mims\,
MD\, MSCR
W
ednesday\, November 3\, 2021
\n7:30-8:30am
Location
strong>
\nRichmond\, IN
Speaker
\nJoshu
a Zeidner\, MD
F
riday\, November 5\, 2021
\n8:00-9:00am
Location
\nSalisbury\, MD
Speaker
\nJoshua
Zeidner\, MD
T
uesday\, November 9\, 2021
\n12:00-1:00pm
Location
\nBrooklyn\, NY
Speaker
\nTapan
M. Kadia\, MD
T
hursday\, November 11\, 2021
\n9:00-10:00am
Location<
/strong>
\nFort Lauderdale\, FL
Speaker
\nDavid Rizzieri\, MD
T
hursday\, November 11\, 2021
\n12:00-1:00pm
Location<
/strong>
\nN/A
Speaker
\nTapan M. Kadia
\, MD
T
hursday\, November 11\, 2021
\n1:00-2:00pm
Location
strong>
\nOrlando\, FL
Speaker
\nDavid
Rizzieri\, MD
W
ednesday\, November 17\, 2021
\n1:15-2:15pm
Location<
/strong>
\nBrooklyn\, NY
Speaker
\nJeff
rey E. Lancet\, MD
F
riday\, November 19\, 2021
\n12:00-1:00pm
Location
\nGoodyear\, AZ
Speaker
\nDavid
Rizzieri\, MD
M
onday\, November 22\, 2021
\n12:00-1:00pm
Location
\nBuffalo\, NY
Speaker
\nAnjali
Advani\, MD
T
uesday\, November 30\, 2021
\n8:00-9:00am
Location
\nGoshen\, IN
Speaker
\nJoshua Z
eidner\, MD
W
ednesday\, December 1\, 2021
\n2:00-3:00pm
Location
strong>
\nNashville\, TN
Speaker
\nAlic
e S. Mims\, MD\, MSCR
Location<
br />\nGeorgia World Congress Center
\n285 Andrew Young Int’
l Blvd. NW
\nAtlanta\, GA 30313
Booth 2471
\nVI SIT OUR VIRTUAL REALITY ROOM – EXHIBIT HALL HOURS
\nSaturda
y\, December 11\, 2021 ~ 11:00 AM – 5:00 PM
\nSunday\, December 12\,
2021 ~ 10:00 AM – 5:00 PM
\nMonday\, December 13\, 2021 ~ 10:00 AM –
2:00 PM
REGISTER FOR LIVE CME PROGRAM a>
\nWednesday\, October 19\, 2022
\n6:00 PM – 8:00 PM EDT
\nVirtual Symposium live at: 6:00 PM Eastern\; 5:00 PM Central\; 4:00 P M Mountain\; 3:00 PM Pacific
\nFACULTY
\n\n | Michael R. Grunwald\
, MD \nChief\, Leukemia Division \nDirector\, Transplan tation and Cellular Therapy Program \nLevine Cancer Institute\, Atriu m Health \nCharlotte\, NC | \n
\n | Ryan Jacobs\, MD \n Principle Investigator of CLL Clinical Trials \nDepartment of Hematol ogy\, Lymphoma Division \nAssistant Professor of Medicine \nLevi ne Cancer Institute\, Atrium Health \nCharlotte\, NC | \n
LEARNING OBJECTIVES
\nUpon the completion of this program\, attendees should be able to:
\nThis virtually live activity is intended for US-based hematologists\, medical oncologists\, and other hea lthcare providers involved in the management of patients with CLL and/or A ML.
\nACCREDITATION STATEMENT
\nMed Learning Group is accredited by the Accreditation Council for Continuing Medical Ed ucation to provide continuing medical education for physicians. This CME a ctivity was planned and produced in accordance with the ACCME Essentials.< /p>\n
CREDIT DESIGNATION STATEMENT
\nMed Learning Group designates this virtually live activity for a maximum of 2. 0 AMA PRA Category 1 CreditsTM. Physicians sh ould claim only the credit commensurate with the extent of their participa tion in the virtually live activity.
\nNURSING CREDIT INFORM ATION
\nPurpose: This program would be beneficial for nurse
s involved in the care of patients with CLL and/or AML.
\nCN
E Credits: 2.0 ANCC Contact Hours
Ultimate Medical Academy/Co mplete Conference Management (CCM) is accredited as a provider of nursing continuing professional education development by the American Nurses Crede ntialing Center’s Commission on Accreditation.
\nAwarded 2.0 contact hour(s) of continuing nursing education of RNs and APNs.
\nDISCLAIMER
\nMed Learning Group makes every effort to devel op CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize t his information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information . The participant should use his/her clinical judgment\, knowledge\, exper ience\, and diagnostic decision-making before applying any information\, w hether provided here or by others\, for any professional use.
\nFor CME questions\, please contact Med Learning Group at info@medlearninggroup.com
\n< p>Contact this CME provider at Med Learning Group for privacy and confiden tiality policy statement information at www.medlearninggroup.com/privacy- policy/\nAMERICANS WITH DISABILITY ACT
\nStaff will be glad to assist you with any special needs. Please contact M ed Learning Group prior to participating at info@medlearninggroup.com
\n\n\n\nREGISTER FOR LIVE VIRTUAL PR OGRAM
\nFriday\, July 14\, 2023
\n12:00PM – 1:00PM ET
\nPlease note this virtual program is 12:00PM Eastern\, 11:00AM Central \, 10:00AM Mountain and 9:00AM Pacific.
\nFACULTY
\n\n | Courtney D. DiNardo\,
MD\, MSCE \nAssociate Professor\, Department of Leukemia \nDivision of Cancer Medicine \nThe University of Texas MD Anderso n Cancer Center | \n
PROGRAM OVERVI EW
\nIn this program\, we will discuss how healthcare provi ders within the Department of Veterans Affairs can improve their treatment of patients with Acute Myeloid Leukemia (AML) by providing updates on key biological features and biomarkers of AML to inform patient assessment wi th novel therapies. In addition\, we will review the latest data in the ma nagement of AML and challenges in effectively communicating rationale for therapeutic decisions with patients and caregivers.
\nTARGET AUDIENCE
\nThis educational activity is intended for US-ba sed hematologists\, medical oncologists\, and other healthcare providers i nvolved in the management of patients with AML within the Department of Ve terans Affairs.
\nEDUCATIONAL OBJECTIVES
\nUp on the completion of this program\, attendees should be able to:
\nACCREDITATION STATEMENT
\nMed Learning Group is accredited
by the Accreditation Council for Continuing Medical Education (ACCME) to p
rovide continuing medical education for physicians.
This CME activ ity was planned and produced in accordance with the ACCME Essentials.
\nPHYSICIAN CREDIT DESIGNATION STATEMENT
\nMed Le
arning Group designates this live activity for a maximum of 1.0 AMA PRA Ca
tegory 1 Credit™. Physicians should claim only the credit commensurate wit
h the extent of their participation in the live activity.
JOINT ACCREDITATION STATEMENT
\nIn support of improving patient care\, this activity has been p lanned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Ed ucation (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\ , and the American Nurses Credentialing Center (ANCC)\, to provide continu ing education for the healthcare team.
\nNURSES (ANCC) CREDI T DESIGNATION
\nAmedco LLC designates this virtually live a ctivity for a maximum of 1.0 ANCC contact hour.
\nDISCLOSURE POLICY STATEMENT
\nIn accordance with the Accreditation Co uncil for Continuing Medical Education ACCME Standards for Integrity and I ndependence in Accredited Continuing Education\, educational programs spon sored by Med Learning Group must demonstrate balance\, independence\, obje ctivity\, and scientific rigor. All faculty\, authors\, editors\, staff\, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relation ship with the manufacturer(s) of any commercial product(s) and/or provider (s) of commercial services that are discussed in an educational activity.< /p>\n
DISCLOSURE OF UNLABELED USE
\nMed Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any c ommercial product or device not yet approved for use in the United States. During the course of this lecture\, the faculty may mention the use of me dications for both FDA-approved and non-approved indications.
\nMed Learning Group makes every effort to d evelop CME activities that are scientifically based. This activity is desi gned for educational purposes. Participants have a responsibility to utili ze this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific informa tion. The participant should use his/her clinical judgment\, knowledge\, e xperience\, and diagnostic decision-making expertise before applying any i nformation\, whether provided here or by others\, for any professional use .
\nFor CME questions\, please contact Med Learning Group at info@medlearninggroup. com
\nContact this CME provider at Med Learning Group for privac y and confidentiality policy statement information at www.medlearninggrou p.com/privacy-policy/
\nAMERICANS WITH DISABILITIES ACT< /strong>
\nEvent staff will be glad to assist you with any special n eeds. Please contact Med Learning Group at info@medlearninggroup.com
\n\n\n\nREGISTER FOR LIVE VIRTUAL PROGRAM
\nThursday\, August 10\, 2023
\n12:00PM – 1:00PM ET
\nPlease note this virtual program is 12:00PM Eastern\, 11:00AM Central\, 10:00AM Mountain and 9:00AM Pacific
\nFACULTY
\n\n | Lori Leslie\, MD \nAssociate Profe ssor of Medicine \nHackensack Meridian Health School of Medicine \nDirector of CLL and Indolent Lymphoma \nJohn Theurer Cancer Center \nHackensack\, NJ | \n
PROGRA M OVERVIEW
\nIn this activity we will discuss the relevance of specific genetic and molecular markers in Chronic Lymphocytic Leukemia (CLL)\, review the current evidence concerning the application of minimal residual disease (MRD) monitoring\, and emerging strategies and combinati ons for CLL management in first-line and relapsed/refractory settings. Fin ally\, we will examine the potential adverse events associated with CLL th erapeutics\, including specific considerations with combination therapies.
\nTARGET AUDIENCE
\nThis educational activit y is intended for community hematologists\, oncologists\, and clinicians i nvolved in the assessment\, monitoring\, and treatment of CLL for patients within the Department of Veteran Affairs.
\nLEARNING OBJECT IVES
\nUpon the completion of this program\, attendees shou ld be able to:
\nACCREDITATION STATEMENT
\nMed Learnin
g Group is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.<
/p>\n
This CME activity was planned and produced in accordance with the ACCME Essentials.
\nPHYSICIAN CREDIT DESIGNATION STATEMENT
strong>
\nMed Learning Group designates this live activity for a maxi
mum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the cr
edit commensurate with the extent of their participation in the live activ
ity.
JOINT ACCREDITATION STATEMENT
\nIn support of improving patient care\, thi s activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharm acy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) \, to provide continuing education for the healthcare team.
\nAmedco LLC designates this virtually live activity for a maximum of 1.0 ANCC contact hour.
\nDISCLOSURE POLICY STATEMENT
\nIn accordance with the Accreditation Council for Continuing Medical Education ACCME Standard s for Integrity and Independence in Accredited Continuing Education\, educ ational programs sponsored by Med Learning Group must demonstrate balance\ , independence\, objectivity\, and scientific rigor. All faculty\, authors \, editors\, staff\, and planning committee members participating in an ML G-sponsored activity are required to disclose any relevant financial inter est or other relationship with the manufacturer(s) of any commercial produ ct(s) and/or provider(s) of commercial services that are discussed in an e ducational activity.
\nDISCLOSURE OF UNLABELED USE< /p>\n
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investi gational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture\, the faculty may mention the use of medications for both FDA-approved and non-approved indi cations.
\nDISCLAIMER
\nMed Learning Group ma kes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a re sponsibility to utilize this information to enhance their professional dev elopment in an effort to improve patient outcomes. Conclusions drawn by th e participants should be derived from careful consideration of all availab le scientific information. The participant should use his/her clinical jud gment\, knowledge\, experience\, and diagnostic decision-making expertise before applying any information\, whether provided here or by others\, for any professional use.
\nFor CME questions\, please contact Med Lear ning Group at i nfo@medlearninggroup.com
\nContact this CME provider at Med Lear ning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
\nAMERICANS W ITH DISABILITIES ACT
\nEvent staff will be glad to assist y ou with any special needs. Please contact Med Learning Group at info@medlearninggroup.com
\n\n\n\nV isit our Virtual Reality Room at Booth 755!
\nExhibit Hall H
ours:
\nDecember 9: 11:00 am – 5:00 pm
\nDecember 10: 1
0:00 am – 5:00 pm
\nDecember 11: 10:00 am – 2:00 pm